Abpro Bio Co., Ltd.

KOSDAQ:A195990 Stock Report

Market Cap: ₩132.9b

Abpro Bio Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jin-Gi Bae

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure4.7yrs

Recent management updates

Recent updates

We Think Abpro Bio (KOSDAQ:195990) Has A Fair Chunk Of Debt

Oct 21
We Think Abpro Bio (KOSDAQ:195990) Has A Fair Chunk Of Debt

Getting In Cheap On Abpro Bio Co., Ltd. (KOSDAQ:195990) Is Unlikely

Jul 12
Getting In Cheap On Abpro Bio Co., Ltd. (KOSDAQ:195990) Is Unlikely

Revenues Not Telling The Story For Abpro Bio Co., Ltd. (KOSDAQ:195990)

Mar 14
Revenues Not Telling The Story For Abpro Bio Co., Ltd. (KOSDAQ:195990)

Is Abpro Bio (KOSDAQ:195990) Using Debt In A Risky Way?

Apr 05
Is Abpro Bio (KOSDAQ:195990) Using Debt In A Risky Way?

Abpro Bio (KOSDAQ:195990) Shareholders Booked A 92% Gain In The Last Year

Feb 02
Abpro Bio (KOSDAQ:195990) Shareholders Booked A 92% Gain In The Last Year

CEO

Jin-Gi Bae

no data

Tenure

Mr. Jin-Gi Bae serves as Chief Executive Officer at UGint Co.Ltd.

Board Members

NamePositionTenureCompensationOwnership
Robert Langer
Director4.7yrsno datano data
Hyun-Woo Lee
Chairmanno datano datano data
Ian Chan
Director4.7yrsno data3.21%
₩ 4.3b
Eugene Chan
Director4.7yrsno datano data

4.7yrs

Average Tenure

51yo

Average Age

Experienced Board: A195990's board of directors are considered experienced (4.7 years average tenure).